Patents by Inventor Michele Mayo

Michele Mayo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230277519
    Abstract: The present invention relates to IRAKIMiD degraders, their liquid formulations, and methods of use thereof for treating cancer.
    Type: Application
    Filed: January 13, 2023
    Publication date: September 7, 2023
    Inventors: Jared Gollob, Jeffrey Davis, Ashwin Gollerkeri, Reginald EWESUEDO, Alice McDonald, Vashali Dixit, Shu-Pei Wu, Michele Mayo, Haojing Rong, Sagar Agarwal, Bradley Enerson, Patrick Henrick, Rachelle Perea, Christopher Ho, William Leong, Duncan Walker
  • Publication number: 20230233546
    Abstract: The present invention relates to methods of treating solid cancers and hematological malignances using MDM2 degraders.
    Type: Application
    Filed: December 15, 2022
    Publication date: July 27, 2023
    Inventors: Stefanie SCHALM, Dapeng Chen, William Proctor, Joseph Growney, Juliet Williams, Brad Enerson, Yogesh Chutake, Michele Mayo, Jianfeng Qi, Chris Ho, Matthew M. Weiss, Haojing Rong
  • Patent number: 9314522
    Abstract: Pharmaceutical composition comprising an antibody specifically recognizing CD38 and bortezomib.
    Type: Grant
    Filed: December 8, 2011
    Date of Patent: April 19, 2016
    Assignee: Sanofi
    Inventors: Jutta Deckert, Pascale Lejeune, Michele Mayo, Peter U. Park
  • Publication number: 20140186337
    Abstract: Pharmaceutical composition comprising an antibody specifically recognizing CD38 and bortezomib.
    Type: Application
    Filed: December 8, 2011
    Publication date: July 3, 2014
    Applicant: SANOFI
    Inventors: Jutta Deckert, Pascale Lejeune, Michele Mayo, Peter U. Park